Archivio Categoria: series A

Ablacon Pulls In $21.5M

Ablacon 4800 Wadsworth Blvd, Suite 310Wheat Ridge, CO 80033303-955-5620http://www.ablacon.com/ Key contact Name Title Duke Rohlen CEO WHEAT RIDGE, CO, Ablacon today announced the closing of a $21.5 million Series A financing round led by Ajax Health. Ablacon, a company developing an advanced mapping system to guide the treatment of atrial fibrillation (AFib), today announced the […]

ManyChat Lands $18M Series A

ManyChat San Francisco, CAhttps://manychat.com/ Key contact Name Title Mikael Yang CEO & Co-Founder SAN FRANCISCO, CA, ManyChat, the Messenger Marketing platform, today announced it has raised $18 million in Series A funding. The round was led by Bessemer Venture Partners. Flint Capital also participated in the round. ManyChat helps small to medium-sized businesses (SMBs) grow […]

Specright Raises $8.8M Series A

Specright 114 Pacifica, Ste. 430Irvine, CA 92618949-386-7334http://specright.com/ Key contact Name Title Matthew Wright CEO IRVINE, CA, Specright announced an $8.8 million Series A round of funding. Specright, Inc., a software company that enables customers to control critical supply chain specifications such as packaging, products, and raw materials, announced today an $8.8 million Series A round […]

Babel Health Secures $5M Series A Funding

Babel Health 106 Isabella St., Suite 102Pittsburgh, PA 15212855-984-1775https://www.babelhealth.com/ Key contact Name Title Robert Dunn CEO PITTSBURGH, PA, Babel Health has completed a $5 million Series-A round of financing. Babel Health, Inc. – provider of an integrated suite of risk adjustment and encounter submission for Medicare/ Medicaid/ ACA software and services for health plans – […]

AskNicely Raises $10M in Series A

AskNicely 1400 NW 22nd Ave., Suite 150Portland, OR 97210https://www.asknicely.com/ Key contact Name Title Aaron Ward CEO PORTLAND, OR, Customer experience platform, today announced a $10 million Series A round. AskNicely, the #1 rated customer experience platform, today announced a USD 10 million Series A round and the launch of Conversations, an intelligent customer feedback framework. […]

Northpass Secures $4M Series A Investment

Northpass 6 Upper Pond RoadParsippany, NJ 07054866-385-8088https://www.northpass.com/ Key contact Name Title Stephen Cornwell CEO PARSIPPANY, NJ, Learning solution for driving business performance, has secured $4 million in Series A funding led by Edison Partners. Northpass, a modern learning solution for driving business performance, has secured $4 million in Series A funding led by Edison Partners, […]

Alt Thirty Six Raises $10M Series A Round

Alt Thirty Six 60 E. Rio Salado Parkway, Suite #900Tempe, AZ 85281https://www.alt36.com/ Key contact Name Title Ken Ramirez CEO & Co-Founder TEMPE, AZ, Alt Thirty Six announces a $10 million in Series A financing round. Alt Thirty Six, a first-of-its-kind digital payment and compliance platform designed to help the cannabis industry go cashless, announces $10 […]

Zippia Raises $8.5M in Series A

Zippia PO Box 14340San Francisco, CA 94114254-294-7742https://www.zippia.com/ Key contact Name Title Henry Shao CEO SAN MATEO, CA, Zippia has raised a Series A investment of $8.5 million, led by E.ventures. Zippia today announced a significant round of funding that will help it continue to build a revolutionary tool for job seekers in their quest for […]

Moveworks Gathers $30M Series A

Moveworks 909 San Rafael Ave.Mountain View, CA 94043https://www.moveworks.com/ Key contact Name Title Bhavin Shah CEO MOUNTAIN VIEW, CA, Moveworks has raised a $30M Series A funding from leading venture capital firms Bain Capital Ventures and Lightspeed Venture Partners. Moveworks today officially introduced the industry's first artificial intelligence (AI) solution to autonomously resolve employee IT issues […]

Talaris Therapeutics Nabs $100M

Talaris Therapeutics 93 Worcester St, Suite 120Wellesley, MA 02481https://talaristx.com/ Key contact Name Title Scott Requadt CEO BOSTON, MA, Talaris Therapeutics today announced the closing of a $100 million Series A financing. Talaris Therapeutics, a privately held biotechnology company developing transformative cell therapies that have the potential to eliminate the burden of chronic immunosuppression for organ […]